Similar Stories to Roche To Take Over Genentech For $47 Billion on Bing News

GENEVA -- Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S.-based cancer drug partner.

Topics:  geneva    swiss   roche   genentech    u.s    billion   
BING NEWS:
  • Roche rings Bicycle bell again, grabbing another cancer target
    Roche's Genentech unit has gone all in on its collaboration with UK biotech Bicycle Therapeutics, taking up an option on a second additional target in the area of cancer immunotherapy. Bicycle's ...
    11/14/2024 - 11:00 am | View Link
  • Roche puts $70m into ArsenalBio's programmable T-cell platform
    Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...
    11/12/2024 - 11:00 am | View Link
  • Genentech terminates agreement for Nykode cancer vaccine program
    Nykode Therapeutics (VACBF) announced last night that it has received notification from Genentech, a member of the Roche (RHHBY), of its ...
    11/8/2024 - 11:01 am | View Link
  • In 'surprise' termination, Genentech drops Nykode partnership for individualized cancer vaccine
    Roche’s Genentech is ending a partnership with Nykode Therapeutics that centered around a clinical-stage cancer vaccine program. | Roche’s Genentech is ending a partnership with Nykode Therapeutics ...
    11/8/2024 - 7:50 am | View Link
  • Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
    Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first patient dosed for a Phase 2 trial in recurrent C. difficile infection, and ...
    11/6/2024 - 8:25 am | View Link
  • More
BING SEARCH:
  • Genentech R&D (gRED)
    Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
    11/16/2024 - 12:04 am | View Website
  • About Us
    Genentech's South San Francisco campus serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development continues to embrace the spirit of a “startup” and operates as a separate business unit within Roche.
    11/15/2024 - 10:28 am | View Website
  • Recursion loops in Roche, Genentech for multibillion-dollar AI drug ...
    The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division. Starting with a hefty $150 million upfront payment,...
    11/15/2024 - 12:41 am | View Website
  • Genentech
    Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. [6] Historically, the company is regarded as the world's first biotechnology company. [7]
    11/14/2024 - 7:16 am | View Website
  • Was The $47 Billion Acquisition of Genentech In 2009 A Good ...
    Roche Holding (NASDAQ:RHHBY) acquired Genentech, a pharmaceuticals company with three blockbuster oncology drugs, in 2009 for a sum of $47 billion. Back in 2008, Genentech’s top drugs were...
    11/13/2024 - 3:17 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News